Tone mix
Week by week 52 weeks
Share of Jazz Pharmaceuticals, Inc.'s 204 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 13, 2025 · tone -100Zacks Research Has Negative Outlook of JAZZ Q3 Earnings-155
- Week of Sep 1, 2025 · tone +100Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $151.00+70
- Week of Jan 5, 2026 · tone +100Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial+65
- Week of Sep 15, 2025 · tone +100Jazz Pharmaceuticals plc (JAZZ) Wins FDA Nod for Modeyso in Rare Pediatric Brain Tumors+59
- Week of Oct 5, 2026 · tone -33Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Lowered at Royal Bank Of Canada-59
- Week of Apr 13, 2026 · tone 0Jazz Pharmaceuticals to Present Xywav Narcolepsy Data at 2026 AAN Annual Meeting-57
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Jazz Pharmaceuticals, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 11 | +45 |
| Last 30 sessions | 20 | +40 |
| Last 90 sessions | 65 | +35 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletJazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $275.00Positive
- www.themarketsdaily.com · 1 outletJazz Pharmaceuticals (NASDAQ:JAZZ) Stock: Insider Renee Gala Sells 1,000 SharesNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Raised to $275.00 | www.dailypolitical.com | 1 | Positive |
| Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock: Insider Renee Gala Sells 1,000 Shares | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletJazz Pharmaceuticals (NASDAQ:JAZZ) Posts Earnings Results, Beats Estimates By $0.16 EPSPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Jazz Pharmaceuticals (NASDAQ:JAZZ) Posts Earnings Results, Beats Estimates By $0.16 EPS | www.tickerreport.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
3 headlines, average tone +66: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.themarketsdaily.com · 1 outletJazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Raised at Royal Bank Of CanadaPositive
- markets.financialcontent.com · 1 outletFinancialContent - Jazz Pharmaceuticals (JAZZ) shares skyrocket, what you need to knowPositive
- www.prnewswire.com · 1 outletJazz Pharmaceuticals to Participate in Upcoming Investor ConferencesNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price Target Raised at Royal Bank Of Canada | www.themarketsdaily.com | 1 | Positive |
| FinancialContent - Jazz Pharmaceuticals (JAZZ) shares skyrocket, what you need to know | markets.financialcontent.com | 1 | Positive |
| Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences | www.prnewswire.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
5 headlines, average tone +20: 1 positive, 4 neutral and 0 negative. Showing all 5.
- www.prnewswire.com · 2 outletsJazz Pharmaceuticals Announces Third Quarter 2026 Financial ResultsNeutral
- markets.financialcontent.com · 1 outletFinancialContent - Jazz Pharmaceuticals (NASDAQ:JAZZ) surprises with Q3 2026 sales, full-year sales guidance is optimisticPositive
- www.themarketsdaily.com · 1 outletJazz Pharmaceuticals (NASDAQ:JAZZ) Announces Quarterly Earnings ResultsNeutral
- www.fool.com · 1 outletJazz (JAZZ) Q3 2026 Earnings Call TranscriptNeutral
- 247wallst.com · 1 outletJazz Pharmaceuticals (JAZZ) Stock Price, News & AnalysisNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results | www.prnewswire.com | 2 | Neutral |
| FinancialContent - Jazz Pharmaceuticals (NASDAQ:JAZZ) surprises with Q3 2026 sales, full-year sales guidance is optimistic | markets.financialcontent.com | 1 | Positive |
| Jazz Pharmaceuticals (NASDAQ:JAZZ) Announces Quarterly Earnings Results | www.themarketsdaily.com | 1 | Neutral |
| Jazz (JAZZ) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
| Jazz Pharmaceuticals (JAZZ) Stock Price, News & Analysis | 247wallst.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletWhere Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth EnginePositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Where Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth Engine | www.fool.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Jazz Pharmaceuticals, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.